This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Menu

Scott Henry
Vice President of Nonclinical Development at Ionis Pharmaceuticals, Inc.

Agenda Sessions

  • Safety Issues Related to Chemically Modified Oligos and Conjugates

    16:30
    View Session

Speakers at this event

Prev
Next
Dominic Hoepfner, Ph.D.
Scientist
Novartis Institutes for BioMedical Research

See Scott Speak

View Agenda